Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Spectrum Laboratory Products, Inc. in July 2019 concerns drug products manufactured or distributed by the company. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be definitively determined from the metadata alone. The warning falls under FDA's drug regulation authority, though the specific issuing office is not identified in the available information. Additional documentation would be needed to identify the particular manufacturing, labeling, or compliance issues that prompted this enforcement action.